PENZBERG, Germany--(BUSINESS WIRE)--Roche (SWX:RO) (SWX:ROG) (Pink Sheets:RHHBY) announced today that it had launched the RTCA Cardio Instrument, the latest member of the xCELLigence product family. The RTCA Cardio Instrument is a medium-throughput cell analyzer that utilizes impedance readings to monitor cardiac beating and cellular events in real time. The instrument features a unique detection rate and frequency measurement concept as well as dedicated software features. Unlike synergistic techniques such as patch clamp, the new system can be used in a fully controlled environment for continuous short-term and long-term experiments, thus increasing the applicable experimental time as well as reproducibility and data quality.
